Ohio State Hematology
@osuhematology.bsky.social
Experts: Research, education, & outstanding clinical care of patients with benign & malignant blood disorders.
🚨 Promotion Alert!
Brad Blaser, MD, PhD, promoted to Associate Professor w/tenure 👏
🔬R01-funded hematopoiesis researcher
🐟OSUCCC Aquatic Facility founder
📊Leads data science workshops
📚Senior author: Cell Reports, JCI, Nature Comms
🎓Advisor to 7 trainees
🧬NIH reviewer
🔗 go.osu.edu/blaser
Brad Blaser, MD, PhD, promoted to Associate Professor w/tenure 👏
🔬R01-funded hematopoiesis researcher
🐟OSUCCC Aquatic Facility founder
📊Leads data science workshops
📚Senior author: Cell Reports, JCI, Nature Comms
🎓Advisor to 7 trainees
🧬NIH reviewer
🔗 go.osu.edu/blaser
June 27, 2025 at 8:00 PM
🚨 Promotion Alert!
Brad Blaser, MD, PhD, promoted to Associate Professor w/tenure 👏
🔬R01-funded hematopoiesis researcher
🐟OSUCCC Aquatic Facility founder
📊Leads data science workshops
📚Senior author: Cell Reports, JCI, Nature Comms
🎓Advisor to 7 trainees
🧬NIH reviewer
🔗 go.osu.edu/blaser
Brad Blaser, MD, PhD, promoted to Associate Professor w/tenure 👏
🔬R01-funded hematopoiesis researcher
🐟OSUCCC Aquatic Facility founder
📊Leads data science workshops
📚Senior author: Cell Reports, JCI, Nature Comms
🎓Advisor to 7 trainees
🧬NIH reviewer
🔗 go.osu.edu/blaser
🎉 Congrats to Dr. Naresh Bumma on his promotion to Associate Professor of Medicine!
🔹 Medical Director, Amyloidosis Clinic
🔹 Strategic Growth Lead, Hematology
🔹 OSU Faculty Council rep
🔹 50+ publications
🔹 ASH committee service
Learn more: cancer.osu.edu/find-a-docto...
🔹 Medical Director, Amyloidosis Clinic
🔹 Strategic Growth Lead, Hematology
🔹 OSU Faculty Council rep
🔹 50+ publications
🔹 ASH committee service
Learn more: cancer.osu.edu/find-a-docto...
June 20, 2025 at 4:16 PM
🎉 Congrats to Dr. Naresh Bumma on his promotion to Associate Professor of Medicine!
🔹 Medical Director, Amyloidosis Clinic
🔹 Strategic Growth Lead, Hematology
🔹 OSU Faculty Council rep
🔹 50+ publications
🔹 ASH committee service
Learn more: cancer.osu.edu/find-a-docto...
🔹 Medical Director, Amyloidosis Clinic
🔹 Strategic Growth Lead, Hematology
🔹 OSU Faculty Council rep
🔹 50+ publications
🔹 ASH committee service
Learn more: cancer.osu.edu/find-a-docto...
Excited to share that Alice Mims, MD, MSCR will be presenting for @peerview.bsky.social w/ @healthtreeorg.bsky.social ’s AML session on May 30!
Catch her live in Chicago or virtually at #ASCO25.
Don’t miss it: bit.ly/AML-T #hematology #AML
Catch her live in Chicago or virtually at #ASCO25.
Don’t miss it: bit.ly/AML-T #hematology #AML
May 7, 2025 at 4:38 PM
Excited to share that Alice Mims, MD, MSCR will be presenting for @peerview.bsky.social w/ @healthtreeorg.bsky.social ’s AML session on May 30!
Catch her live in Chicago or virtually at #ASCO25.
Don’t miss it: bit.ly/AML-T #hematology #AML
Catch her live in Chicago or virtually at #ASCO25.
Don’t miss it: bit.ly/AML-T #hematology #AML
Just wrapped up our first-ever Acute Leukemia Retreat—what an inspiring day! 💪 So many brilliant minds came together to share knowledge, spark ideas, and build connections. Grateful to all our speakers and attendees! 🧠✨
📸 Swipe to see the speaker collage + group photo!
📸 Swipe to see the speaker collage + group photo!
April 18, 2025 at 8:53 PM
Just wrapped up our first-ever Acute Leukemia Retreat—what an inspiring day! 💪 So many brilliant minds came together to share knowledge, spark ideas, and build connections. Grateful to all our speakers and attendees! 🧠✨
📸 Swipe to see the speaker collage + group photo!
📸 Swipe to see the speaker collage + group photo!
👏Congrats to Yazeed Sawalha, MD, who published "Outcomes of patients w/ relapsed/refractory lymphoplasmacytic lymphoma/waldenström macroglobulinemia treated with venetoclax: a multicenter retrospective analysis" in Blood Cancer Jnl.⭐️
www.nature.com/articles/s41...
www.nature.com/articles/s41...
April 16, 2025 at 7:28 PM
👏Congrats to Yazeed Sawalha, MD, who published "Outcomes of patients w/ relapsed/refractory lymphoplasmacytic lymphoma/waldenström macroglobulinemia treated with venetoclax: a multicenter retrospective analysis" in Blood Cancer Jnl.⭐️
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Congrats to Dr. Alice Mims on receiving an MPI NCI R01 award with/ Dr. Christopher Coss (OSU Pharmacy & UCincyMedicine) to study pharmacodynamically directed targeted therapy for leukemia using a DHODH inhibitor developed at OSU through the DDI. 🔬🧬 #AML #MDS #CancerResearch
April 15, 2025 at 4:19 PM
Congrats to Dr. Alice Mims on receiving an MPI NCI R01 award with/ Dr. Christopher Coss (OSU Pharmacy & UCincyMedicine) to study pharmacodynamically directed targeted therapy for leukemia using a DHODH inhibitor developed at OSU through the DDI. 🔬🧬 #AML #MDS #CancerResearch
Carrie Trojack, an OSU employee + leukemia survivor, is raising $100K for the #VisionaryOfTheYear campaign. She's proof that hope and healing can spark change.
🧡 Support her mission: pages.lls.org/voy/coh/colu...
🧡 Support her mission: pages.lls.org/voy/coh/colu...
April 15, 2025 at 2:50 PM
Carrie Trojack, an OSU employee + leukemia survivor, is raising $100K for the #VisionaryOfTheYear campaign. She's proof that hope and healing can spark change.
🧡 Support her mission: pages.lls.org/voy/coh/colu...
🧡 Support her mission: pages.lls.org/voy/coh/colu...
Timothy Voorhees, MD @tvoorheesmd.bsky.social published "Outcomes in patients with classic #Hodgkinlymphoma refractory or intolerant to brentuximab vedotin and anti-PD-1 therapy: a real world analysis from 15 U.S. academic centers" in @BloodCancerJnl.
🔗https://pubmed.ncbi.nlm.nih.gov/40140364/
🔗https://pubmed.ncbi.nlm.nih.gov/40140364/
April 8, 2025 at 5:07 PM
Timothy Voorhees, MD @tvoorheesmd.bsky.social published "Outcomes in patients with classic #Hodgkinlymphoma refractory or intolerant to brentuximab vedotin and anti-PD-1 therapy: a real world analysis from 15 U.S. academic centers" in @BloodCancerJnl.
🔗https://pubmed.ncbi.nlm.nih.gov/40140364/
🔗https://pubmed.ncbi.nlm.nih.gov/40140364/
Uma Borate, MD, MS published "Reducing clinical trial eligibility barriers for patients with #MDS: an icMDS position statement" @BloodJournal!
🔗https://pubmed.ncbi.nlm.nih.gov/40146152/
🔗https://pubmed.ncbi.nlm.nih.gov/40146152/
April 8, 2025 at 5:06 PM
Uma Borate, MD, MS published "Reducing clinical trial eligibility barriers for patients with #MDS: an icMDS position statement" @BloodJournal!
🔗https://pubmed.ncbi.nlm.nih.gov/40146152/
🔗https://pubmed.ncbi.nlm.nih.gov/40146152/
Dr. Wall (@sarahallison10.bsky.social) published an article in the Annals of Hematology Journal.
🔗https://pubmed.ncbi.nlm.nih.gov/40119918/
🔗https://pubmed.ncbi.nlm.nih.gov/40119918/
April 8, 2025 at 5:03 PM
Dr. Wall (@sarahallison10.bsky.social) published an article in the Annals of Hematology Journal.
🔗https://pubmed.ncbi.nlm.nih.gov/40119918/
🔗https://pubmed.ncbi.nlm.nih.gov/40119918/
Strikes, Smiles & Spring Vibes –
Hematology Hits the Lanes! 🎳
Great to relax and have some fun with colleagues and our families at the Spring Celebration last Saturday. Thanks to everyone who made it happen! 💙
Hematology Hits the Lanes! 🎳
Great to relax and have some fun with colleagues and our families at the Spring Celebration last Saturday. Thanks to everyone who made it happen! 💙
April 8, 2025 at 4:43 PM
Strikes, Smiles & Spring Vibes –
Hematology Hits the Lanes! 🎳
Great to relax and have some fun with colleagues and our families at the Spring Celebration last Saturday. Thanks to everyone who made it happen! 💙
Hematology Hits the Lanes! 🎳
Great to relax and have some fun with colleagues and our families at the Spring Celebration last Saturday. Thanks to everyone who made it happen! 💙
Reposted by Ohio State Hematology
Very proud to have played a role in this study with my study chair Dr. Eric Huselton from University of Rochester - please consider your patients for this study @osuhematology.bsky.social @osucccjames.bsky.social @swog.org @ash.hematology.org
#myeloMATCH sub-study MM1OA-S03 is open!
Patients registered to MYELOMATCH screening protocol who are 60+ or unfit for chemo and have AML w an IDH2 gene mutation may be assigned. Randomized to venetoclax + ASTX727 w/wo enasidenib.
swog.org/clinical-trials/MM1OA-S03 @beatalleukemia.bsky.social
Patients registered to MYELOMATCH screening protocol who are 60+ or unfit for chemo and have AML w an IDH2 gene mutation may be assigned. Randomized to venetoclax + ASTX727 w/wo enasidenib.
swog.org/clinical-trials/MM1OA-S03 @beatalleukemia.bsky.social
April 2, 2025 at 7:18 PM
Very proud to have played a role in this study with my study chair Dr. Eric Huselton from University of Rochester - please consider your patients for this study @osuhematology.bsky.social @osucccjames.bsky.social @swog.org @ash.hematology.org
Happy (belated) Doctor’s Day! 🎉 A huge thank you to our incredible Heme faculty for your dedication, compassion, and expertise. Your impact on patients and advancements in research are truly inspiring. We’re grateful for all you do! ❤️ #DoctorsDay #HematologyHeroes
March 31, 2025 at 3:23 PM
Happy (belated) Doctor’s Day! 🎉 A huge thank you to our incredible Heme faculty for your dedication, compassion, and expertise. Your impact on patients and advancements in research are truly inspiring. We’re grateful for all you do! ❤️ #DoctorsDay #HematologyHeroes
Dr. Krull (@ashleyakrull.bsky.social) is looking forward to the ISCT Annual Meeting in New Orleans! 🎉 If you haven’t registered yet, don’t miss out—this is the one CGT conference not to skip! 🔬✨ #CellTherapy #GeneTherapy #ISCT2025
March 19, 2025 at 3:54 PM
Dr. Krull (@ashleyakrull.bsky.social) is looking forward to the ISCT Annual Meeting in New Orleans! 🎉 If you haven’t registered yet, don’t miss out—this is the one CGT conference not to skip! 🔬✨ #CellTherapy #GeneTherapy #ISCT2025
🎉 Congrats to Annika Chura from Dr. Bradley Blaser’s lab for winning 1st place at the Hayes Advanced Research Forum! 🏆👏
Her project highlights key insights into AML research. 🔬💡
mcdb.osu.edu/news/mcdb-st...
Her project highlights key insights into AML research. 🔬💡
mcdb.osu.edu/news/mcdb-st...
March 18, 2025 at 9:08 PM
🎉 Congrats to Annika Chura from Dr. Bradley Blaser’s lab for winning 1st place at the Hayes Advanced Research Forum! 🏆👏
Her project highlights key insights into AML research. 🔬💡
mcdb.osu.edu/news/mcdb-st...
Her project highlights key insights into AML research. 🔬💡
mcdb.osu.edu/news/mcdb-st...
🔬From months in the hospital to nights at home—#bmtsm
OSU James Cancer Center.
has come a long way!
Sapp(1984) & Burnworth(2017) both beat leukemia thanks to expert care.
Drs de Lima, Vasu, & @sarahallison10.bsky.social are leading the next breakthrough: outpatient transplants. go.osu.edu/bmtsm
OSU James Cancer Center.
has come a long way!
Sapp(1984) & Burnworth(2017) both beat leukemia thanks to expert care.
Drs de Lima, Vasu, & @sarahallison10.bsky.social are leading the next breakthrough: outpatient transplants. go.osu.edu/bmtsm
Advances in bone marrow transplant
The Blood and Marrow Transplant Program at @OSUCCC_James has a more-than-40-year history with many successes and advancements, including expanded donor options and outpatient treatment plans.
health.osu.edu
March 14, 2025 at 5:57 PM
🔬From months in the hospital to nights at home—#bmtsm
OSU James Cancer Center.
has come a long way!
Sapp(1984) & Burnworth(2017) both beat leukemia thanks to expert care.
Drs de Lima, Vasu, & @sarahallison10.bsky.social are leading the next breakthrough: outpatient transplants. go.osu.edu/bmtsm
OSU James Cancer Center.
has come a long way!
Sapp(1984) & Burnworth(2017) both beat leukemia thanks to expert care.
Drs de Lima, Vasu, & @sarahallison10.bsky.social are leading the next breakthrough: outpatient transplants. go.osu.edu/bmtsm
The 2025 @castleconnolly.bsky.social Exceptional Women in Medicine is out!🎉This honor celebrates🔝female physicians for their leadership & expertise.
👏 Congrats to the OSUCCCJames Heme honorees:
Jennifer Woyach
Uma Borate @beatalleukemia.bsky.social
Alice Mims
Ashley Rosko
Kami Maddocks
Kerry Rogers
👏 Congrats to the OSUCCCJames Heme honorees:
Jennifer Woyach
Uma Borate @beatalleukemia.bsky.social
Alice Mims
Ashley Rosko
Kami Maddocks
Kerry Rogers
March 12, 2025 at 5:35 PM
The 2025 @castleconnolly.bsky.social Exceptional Women in Medicine is out!🎉This honor celebrates🔝female physicians for their leadership & expertise.
👏 Congrats to the OSUCCCJames Heme honorees:
Jennifer Woyach
Uma Borate @beatalleukemia.bsky.social
Alice Mims
Ashley Rosko
Kami Maddocks
Kerry Rogers
👏 Congrats to the OSUCCCJames Heme honorees:
Jennifer Woyach
Uma Borate @beatalleukemia.bsky.social
Alice Mims
Ashley Rosko
Kami Maddocks
Kerry Rogers
🗞️ Dr. Devarakonda joins the @abimcert.bsky.social Hematology Item-Writing Task Force to help craft questions for Heme Certification exams, including LKA for MOC. #Hematology #MedicalEducation
March 11, 2025 at 5:33 PM
🗞️ Dr. Devarakonda joins the @abimcert.bsky.social Hematology Item-Writing Task Force to help craft questions for Heme Certification exams, including LKA for MOC. #Hematology #MedicalEducation
⚽️👩⚕️History made!
Dr. Sarah Wall formed the 1st-ever US Women’s Medical Soccer Team at the Physician Soccer Summit.🇺🇸 After attending solo last year, she recruited 15 women to join, and now the team is heading to the World Medical Football Championships in Dublin, Ireland July 2025! 🇮🇪🏆
Dr. Sarah Wall formed the 1st-ever US Women’s Medical Soccer Team at the Physician Soccer Summit.🇺🇸 After attending solo last year, she recruited 15 women to join, and now the team is heading to the World Medical Football Championships in Dublin, Ireland July 2025! 🇮🇪🏆
March 7, 2025 at 5:16 PM
⚽️👩⚕️History made!
Dr. Sarah Wall formed the 1st-ever US Women’s Medical Soccer Team at the Physician Soccer Summit.🇺🇸 After attending solo last year, she recruited 15 women to join, and now the team is heading to the World Medical Football Championships in Dublin, Ireland July 2025! 🇮🇪🏆
Dr. Sarah Wall formed the 1st-ever US Women’s Medical Soccer Team at the Physician Soccer Summit.🇺🇸 After attending solo last year, she recruited 15 women to join, and now the team is heading to the World Medical Football Championships in Dublin, Ireland July 2025! 🇮🇪🏆
March is #MyelomaAwarenessMonth!🎗️
Dr. Naresh Bumma recently spoke w/ CitySceneColumbus about the latest advancements in #MM.
🧬🔬
Check out the article here! 👇
www.cityscenecolumbus.com/arts-and-ent...
Dr. Naresh Bumma recently spoke w/ CitySceneColumbus about the latest advancements in #MM.
🧬🔬
Check out the article here! 👇
www.cityscenecolumbus.com/arts-and-ent...
OSUCCC – James makes significant breakthroughs in multiple myeloma research
Leading the fight.
www.cityscenecolumbus.com
March 7, 2025 at 5:12 PM
March is #MyelomaAwarenessMonth!🎗️
Dr. Naresh Bumma recently spoke w/ CitySceneColumbus about the latest advancements in #MM.
🧬🔬
Check out the article here! 👇
www.cityscenecolumbus.com/arts-and-ent...
Dr. Naresh Bumma recently spoke w/ CitySceneColumbus about the latest advancements in #MM.
🧬🔬
Check out the article here! 👇
www.cityscenecolumbus.com/arts-and-ent...
🎉 Congrats to @akeisfeld.bsky.social ! 🎉
Dr. Eisfeld is a 2024 recipient of the $75K Real-World Data Impact Award from
@americancancersoc.bsky.social r
& @FlatironHealth
Plus, Dr. Eisfeld gains access to Flatiron AML data (valued at ~$500K) for a year! 🔬📊 #CancerResearch #PublicHealth
Dr. Eisfeld is a 2024 recipient of the $75K Real-World Data Impact Award from
@americancancersoc.bsky.social r
& @FlatironHealth
Plus, Dr. Eisfeld gains access to Flatiron AML data (valued at ~$500K) for a year! 🔬📊 #CancerResearch #PublicHealth
March 7, 2025 at 4:45 PM
🎉 Congrats to @akeisfeld.bsky.social ! 🎉
Dr. Eisfeld is a 2024 recipient of the $75K Real-World Data Impact Award from
@americancancersoc.bsky.social r
& @FlatironHealth
Plus, Dr. Eisfeld gains access to Flatiron AML data (valued at ~$500K) for a year! 🔬📊 #CancerResearch #PublicHealth
Dr. Eisfeld is a 2024 recipient of the $75K Real-World Data Impact Award from
@americancancersoc.bsky.social r
& @FlatironHealth
Plus, Dr. Eisfeld gains access to Flatiron AML data (valued at ~$500K) for a year! 🔬📊 #CancerResearch #PublicHealth